2.98

1.62% -0.10

Artelo Biosciences Inc (ARTL)

Overview News Price History Financials Discussions Forecast Stock Split

Artelo Biosciences Inc stock is traded at $2.98, with a volume of 57,661. It is down -1.62% in the last 24 hours and down -54.16% over the past month. Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Previous Close:

$3.08

Open:

$3.02

24h Volume:

57,661

Relative Volume:

0.02

Market Cap:

$2.78M

Revenue:

Net Income/Loss:

$-12.88M

P/E Ratio:

-0.0836

EPS:

-35.6417

Net Cash Flow:

$-8.79M

1W Performance:

-11.14%

1M Performance:

-54.16%

6M Performance:

-45.41%

1Y Performance:

-83.17%

1-Day Range:

$2.96

$3.04

1-Week Range:

$2.96

$3.5671

52-Week Range:

$2.955

$85.80

Artelo Biosciences Inc Stock (ARTL) Company Profile

Name

Artelo Biosciences Inc

Sector

Healthcare (1107)

Industry

Biotechnology (615)

Phone

858-925-7049

Address

505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA

Employee

Twitter

@ArteloBio

Next Earnings Date

2026-05-12

Latest SEC Filings

ARTL's Discussions on Twitter

Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ARTL Artelo Biosciences Inc	2.96	2.89M	0	-12.88M	-8.79M	-35.64
VRTX Vertex Pharmaceuticals Inc	428.69	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.51	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.49	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	305.51	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.49	33.06B	5.36B	287.73M	924.18M	2.5229

Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-25	Upgrade	D. Boral Capital	Hold → Buy
Feb-12-21	Initiated	Ladenburg Thalmann	Buy

Artelo Biosciences Inc Stock (ARTL) Latest News

May 05, 2026

Artelo Biosciences | S-3: Registration statement for specified transactions by certain issuers - Moomoo

May 05, 2026

May 04, 2026

Artelo Biosciences may offer securities up to $75 millionSEC filing - marketscreener.com

May 04, 2026

Artelo Biosciences (NASDAQ: ARTL) files $75M shelf, includes $69.29M unsold - Stock Titan

May 04, 2026

May 01, 2026

What's behind the rise in Artelo Biosciences stock? - MSN

May 01, 2026

Apr 30, 2026

Why did ARTL stock skyrocket over 141% pre-market today? - MSN

Apr 30, 2026

Avis Budget Group, Toyota Motor and other big stocks moving lower in Monday's pre-market session - MSN

Apr 30, 2026

Apr 28, 2026

Artelo Biosciences (ARTL) Partners with ScienceMachine for AI-Dr - GuruFocus

Apr 28, 2026

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - The Manila Times

Apr 28, 2026

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence Leader Sciencemachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - marketscreener.com

Apr 28, 2026

Apr 27, 2026

Artelo (ARTL) Stock Fundamentals | Q4 2025: EPS Exceeds ExpectationsRetail Trader Ideas - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

ARTL (Artelo Biosciences Inc.) delivers 97.5 percent positive Q4 2025 EPS surprise, but shares drop 8.64 percent today. - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 21, 2026

What's Behind The Rise In Artelo Biosciences Stock? - Sahm

Apr 21, 2026

Apr 20, 2026

Artelo Biosciences (ARTL) Publishes Insightful Research on Pain Management - GuruFocus

Apr 20, 2026

Artelo (ARTL) Stock Short Interest Analysis (Smart Money Flows) 2026-04-20Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

ARTL Stock In Play As Pipeline Expands And Nasdaq Risk Eases - StocksToTrade

Apr 20, 2026

ARTL Stock Draws Traders As Biotech Pipeline Expands - timothysykes.com

Apr 20, 2026

Artelo Biosciences jumps after Nasdaq compliance update, with low-float volatility likely adding fuel - Quiver Quantitative

Apr 20, 2026

ARTL Stock Whipsaws As Artelo Biosciences Expands High-Risk, High-Reward Pipeline - timothysykes.com

Apr 20, 2026

Top movers in Monday's pre-market session - ChartMill

Apr 20, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 20, 2026

Artelo Biosciences Highlights Promising Efficacy and Safety Profile of ART26.12 as a Novel Pain Treatment Ahead of Upcoming Clinical Studies - Quiver Quantitative

Apr 20, 2026

Artelo says non-opioid pain drug had no serious drug-related events - Stock Titan

Apr 20, 2026

Apr 19, 2026